Amgen Beats Second-Quarter Expectations, So Why Are Sharing Diving?Investors Business Daily • 08/05/25
Former Amgen SVP of Global Research and Renowned Cell Biologist Ray Deshaies Named to Iambic's Scientific Advisory BoardBusiness Wire • 08/05/25
Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?Zacks Investment Research • 08/04/25
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challengesWSJ • 08/01/25
Gear Up for Amgen (AMGN) Q2 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 07/31/25
Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?Zacks Investment Research • 07/30/25
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical OfficerGlobeNewsWire • 07/21/25
Amgen (AMGN) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 07/18/25
Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And MoreSeeking Alpha • 07/18/25